These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 9638684
1. CYP2D1 polymorphism in methamphetamine-treated rats: genetic differences in neonatal mortality and effects on spatial learning and acoustic startle. Vorhees CV, Reed TM, Schilling MA, Fisher JE, Moran MS, Cappon GD, Nebert DW. Neurotoxicol Teratol; 1998; 20(3):265-73. PubMed ID: 9638684 [Abstract] [Full Text] [Related]
10. Effects of (+)-methamphetamine on path integration and spatial learning, but not locomotor activity or acoustic startle, align with the stress hyporesponsive period in rats. Vorhees CV, Skelton MR, Grace CE, Schaefer TL, Graham DL, Braun AA, Williams MT. Int J Dev Neurosci; 2009 May; 27(3):289-98. PubMed ID: 19136054 [Abstract] [Full Text] [Related]
12. Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze. Williams MT, Moran MS, Vorhees CV. Psychopharmacology (Berl); 2003 Jul; 168(3):329-38. PubMed ID: 12684734 [Abstract] [Full Text] [Related]
14. Does effect from developmental methamphetamine exposure on spatial learning and memory depend on stage of neuroontogeny? Hrebíčková I, Ševčíková M, Nohejlová K, Šlamberová R. Physiol Res; 2016 Dec 22; 65(Suppl 5):S577-S589. PubMed ID: 28006940 [Abstract] [Full Text] [Related]
15. Periadolescent rats (P41-50) exhibit increased susceptibility to D-methamphetamine-induced long-term spatial and sequential learning deficits compared to juvenile (P21-30 or P31-40) or adult rats (P51-60). Vorhees CV, Reed TM, Morford LL, Fukumura M, Wood SL, Brown CA, Skelton MR, McCrea AE, Rock SL, Williams MT. Neurotoxicol Teratol; 2005 Dec 22; 27(1):117-34. PubMed ID: 15681126 [Abstract] [Full Text] [Related]
16. Stage-specific effects of prenatal d-methamphetamine exposure on behavioral and eye development in rats. Acuff-Smith KD, Schilling MA, Fisher JE, Vorhees CV. Neurotoxicol Teratol; 1996 Dec 22; 18(2):199-215. PubMed ID: 8709932 [Abstract] [Full Text] [Related]
17. Acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA) in Sprague-Dawley and Dark Agouti rats. Malpass A, White JM, Irvine RJ, Somogyi AA, Bochner F. Pharmacol Biochem Behav; 1999 Sep 22; 64(1):29-34. PubMed ID: 10494994 [Abstract] [Full Text] [Related]
18. Effects of Housing on Methamphetamine-Induced Neurotoxicity and Spatial Learning and Memory. Gutierrez A, Jablonski SA, Amos-Kroohs RM, Barnes AC, Williams MT, Vorhees CV. ACS Chem Neurosci; 2017 Jul 19; 8(7):1479-1489. PubMed ID: 28287691 [Abstract] [Full Text] [Related]
19. Molecular basis of the Dark Agouti rat drug oxidation polymorphism: importance of CYP2D1 and CYP2D2. Yamamoto Y, Tasaki T, Nakamura A, Iwata H, Kazusaka A, Gonzalez FJ, Fujita S. Pharmacogenetics; 1998 Feb 19; 8(1):73-82. PubMed ID: 9511184 [Abstract] [Full Text] [Related]
20. Distinct periods of developmental sensitivity to the effects of 3,4-(±)-methylenedioxymethamphetamine (MDMA) on behaviour and monoamines in rats. Skelton MR, Graham DL, Schaefer TL, Grace CE, Braun AA, Burns LN, Amos-Kroohs RM, Williams MT, Vorhees CV. Int J Neuropsychopharmacol; 2012 Jul 19; 15(6):811-24. PubMed ID: 21733225 [Abstract] [Full Text] [Related] Page: [Next] [New Search]